Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Mitochondrial disease

Gene: MRPS22

Green List (high evidence)

MRPS22 (mitochondrial ribosomal protein S22)
EnsemblGeneIds (GRCh38): ENSG00000175110
EnsemblGeneIds (GRCh37): ENSG00000175110
OMIM: 605810, Gene2Phenotype
MRPS22 is in 9 panels

2 reviews

Elena Savva (Victorian Clinical Genetics Services)

Green List (high evidence)

Variant affects mito function -> COPD
Variant doesn’t affect mito function -> OD
- Homozygous missense have been reported to cause either condition, functional evidence the only difference.
- Chet (missense/PTC) have been reported to cause COPD
- Structural analysis suggests that variant location could explain the different phenotypes: missense variants identified in individuals with the milder OD phenotype are situated in an internal region of MRPS22 while missense variants identified in individuals with the more severe COPD phenotype are postulated to indirectly cause disruption of protein:protein interfaces (this is from one report (PMID: 29566152) and more evidence is needed to confirm this)
Created: 8 Jan 2021, 1:53 a.m. | Last Modified: 8 Jan 2021, 1:53 a.m.
Panel Version: 0.6019

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Combined oxidative phosphorylation deficiency 5 MIM#611719; Ovarian dysgenesis 7 MIM#618117

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Combined oxidative phosphorylation deficiency 5, MIM# 611719

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
  • Australian Genomics Health Alliance Mitochondrial Flagship
Phenotypes
  • Combined oxidative phosphorylation deficiency 5, MIM# 611719
OMIM
605810
Clinvar variants
Variants in MRPS22
Penetrance
None
Publications
Panels with this gene

History Filter Activity

12 Apr 2020, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: mrps22 has been classified as Green List (High Evidence).

12 Apr 2020, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: MRPS22 were changed from to Combined oxidative phosphorylation deficiency 5, MIM# 611719

12 Apr 2020, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: MRPS22 were set to

12 Apr 2020, Gel status: 3

Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Mode of inheritance for gene: MRPS22 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal

17 Nov 2019, Gel status: 3

Created, Added New Source, Set mode of inheritance

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: MRPS22 was added gene: MRPS22 was added to Mitochondrial_AGHA_VCGS. Sources: Expert Review Green,Australian Genomics Health Alliance Mitochondrial Flagship,Victorian Clinical Genetics Services Mode of inheritance for gene: MRPS22 was set to Unknown